Racial/ethnic differences in the prevalence and incidence of metabolic syndrome in high-income countries: a protocol for a systematic review.
Ethnicity
High-income countries
Metabolic syndrome (MetS)
Migrants
Race
Journal
Systematic reviews
ISSN: 2046-4053
Titre abrégé: Syst Rev
Pays: England
ID NLM: 101580575
Informations de publication
Date de publication:
08 06 2020
08 06 2020
Historique:
received:
30
12
2019
accepted:
27
05
2020
entrez:
10
6
2020
pubmed:
10
6
2020
medline:
25
6
2021
Statut:
epublish
Résumé
Metabolic syndrome is a constellation of various cardiovascular and type 2 diabetes risk factors, such as abdominal obesity, atherogenic dyslipidemia, high blood pressure, and high blood glucose, but its prevalence varies widely by geographical region, sex, and race/ethnicity. The objective of this study is to examine the prevalence and incidence of metabolic syndrome among adults of different racial/ethnic origins in high-income countries. We designed and registered a study protocol for a systematic review of descriptive epidemiological data. Observational studies (e.g., cross sectional and cohort studies) reporting morbidity data of metabolic syndrome and conducted in a wide range of adult people (e.g., different racial/ethnic origins, including migrants) will be included. The primary outcome will be the prevalence and incidence of metabolic syndrome. Secondary outcomes will be the prevalence and incidence of individual components of metabolic syndrome (e.g., abdominal obesity, dyslipidemia, high blood pressure, and high blood glucose). Literature searches will be conducted in several electronic databases (from inception onwards), including MEDLINE, Web of Science Core Collection (Science Citation Index and Social Science Citation Index), CINAHL, and Cochrane Library. Two investigators will independently screen all reference titles, abstracts, and full-text articles. The methodological quality (or potential bias) of selected studies will be appraised using an appropriate tool. Our results will be described narratively. Random-effects meta-analysis will be conducted, if feasible and appropriate. Additional analyses will be conducted to explore the potential sources of heterogeneity. This systematic review will identify, evaluate, and integrate prevalence and incidence data of metabolic syndrome, with focus on racial/ethnic differences in high-income countries. We anticipate our findings may guide policy formulation and identify knowledge gaps in the literature that future research should address. PROSPERO, CRD42020157189.
Sections du résumé
BACKGROUND
Metabolic syndrome is a constellation of various cardiovascular and type 2 diabetes risk factors, such as abdominal obesity, atherogenic dyslipidemia, high blood pressure, and high blood glucose, but its prevalence varies widely by geographical region, sex, and race/ethnicity. The objective of this study is to examine the prevalence and incidence of metabolic syndrome among adults of different racial/ethnic origins in high-income countries.
METHODS
We designed and registered a study protocol for a systematic review of descriptive epidemiological data. Observational studies (e.g., cross sectional and cohort studies) reporting morbidity data of metabolic syndrome and conducted in a wide range of adult people (e.g., different racial/ethnic origins, including migrants) will be included. The primary outcome will be the prevalence and incidence of metabolic syndrome. Secondary outcomes will be the prevalence and incidence of individual components of metabolic syndrome (e.g., abdominal obesity, dyslipidemia, high blood pressure, and high blood glucose). Literature searches will be conducted in several electronic databases (from inception onwards), including MEDLINE, Web of Science Core Collection (Science Citation Index and Social Science Citation Index), CINAHL, and Cochrane Library. Two investigators will independently screen all reference titles, abstracts, and full-text articles. The methodological quality (or potential bias) of selected studies will be appraised using an appropriate tool. Our results will be described narratively. Random-effects meta-analysis will be conducted, if feasible and appropriate. Additional analyses will be conducted to explore the potential sources of heterogeneity.
CONCLUSION
This systematic review will identify, evaluate, and integrate prevalence and incidence data of metabolic syndrome, with focus on racial/ethnic differences in high-income countries. We anticipate our findings may guide policy formulation and identify knowledge gaps in the literature that future research should address.
SYSTEMATIC REVIEW REGISTRATION
PROSPERO, CRD42020157189.
Identifiants
pubmed: 32513278
doi: 10.1186/s13643-020-01400-y
pii: 10.1186/s13643-020-01400-y
pmc: PMC7282095
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
134Références
J Am Coll Cardiol. 2010 Sep 28;56(14):1113-32
pubmed: 20863953
Circulation. 2009 Oct 20;120(16):1640-5
pubmed: 19805654
Am J Med. 2006 Oct;119(10):812-9
pubmed: 17000207
Res Synth Methods. 2017 Sep;8(3):281-289
pubmed: 28453179
Stroke. 2008 Jan;39(1):30-5
pubmed: 18063821
BMJ. 1997 Sep 13;315(7109):629-34
pubmed: 9310563
Syst Rev. 2015 Jan 01;4:1
pubmed: 25554246
Eur J Prev Cardiol. 2015 Apr;22(4):486-91
pubmed: 24647805
JAMA. 2000 Apr 19;283(15):2008-12
pubmed: 10789670
J Am Coll Cardiol. 2013 Aug 20;62(8):697-703
pubmed: 23810877
Int J Obes (Lond). 2014 Sep;38 Suppl 2:S4-14
pubmed: 25376220
PLoS One. 2012;7(9):e46365
pubmed: 23029497
Metab Syndr Relat Disord. 2014 Oct;12(8):430-6
pubmed: 25045798
BMC Med. 2011 May 05;9:48
pubmed: 21542944
Circulation. 2002 Dec 17;106(25):3143-421
pubmed: 12485966
J Eval Clin Pract. 2012 Feb;18(1):12-8
pubmed: 20698919
Ann Intern Med. 2009 Aug 18;151(4):264-9, W64
pubmed: 19622511
Am J Hum Genet. 1997 Jan;60(1):188-96
pubmed: 8981962
Circulation. 2004 Sep 7;110(10):1245-50
pubmed: 15326067
Appl Physiol Nutr Metab. 2019 Aug;44(8):861-868
pubmed: 30640516
Endocrinol Metab Clin North Am. 2004 Jun;33(2):351-75, table of contents
pubmed: 15158523
Diabetes Res Clin Pract. 2007 Sep;77(3):471-8
pubmed: 17350710
J Hum Hypertens. 2007 Mar;21(3):183-211
pubmed: 17301805
JAMA. 2002 Jan 16;287(3):356-9
pubmed: 11790215
Diabet Med. 1999 May;16(5):442-3
pubmed: 10342346
Diabetes Care. 2004 Mar;27(3):788-93
pubmed: 14988303
Lancet. 2005 Sep 24-30;366(9491):1059-62
pubmed: 16182882
Eur J Public Health. 2019 Oct 1;29(5):906-913
pubmed: 31220248
Diabetes Care. 2005 Nov;28(11):2745-9
pubmed: 16249550
J Epidemiol Community Health. 2011 May;65(5):467-72
pubmed: 21282138
Diabetes Care. 2001 Apr;24(4):683-9
pubmed: 11315831
Diabetes. 1992 Jun;41(6):715-22
pubmed: 1587398
Diabet Med. 1998 Jul;15(7):539-53
pubmed: 9686693
Cochrane Database Syst Rev. 2019 Apr 15;4:CD008205
pubmed: 30985922
Diabet Med. 2006 May;23(5):469-80
pubmed: 16681555
Circulation. 2005 Oct 25;112(17):2735-52
pubmed: 16157765